Author:
Sottile Peter D.,Iturbe David,Katsumoto Tamiko R.,Connolly M. Kari,Collard Harold R.,Leard Lorriana A.,Hays Steven,Golden Jeffrey A.,Hoopes Charles,Kukreja Jasleen,Singer Jonathan P.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference25 articles.
1. Changes in causes of death in systemic sclerosis, 1972-2002.;Steen;Ann Rheum Dis,2007
2. . Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era.;Condliffe;Am J Respir Crit Care Med,2009
3. . Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.;Tashkin;Am J Respir Crit Care Med,2007
4. . A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.;Hoyles;Arthritis Rheum,2006
5. Mycophenolate mofetil as first-line treatment improves clinically evident early scleroderma lung disease.;Liossis;Rheumatology (Oxf),2006
Cited by
78 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献